更准确地讲，本发明涉及命名为PAM4的肿瘤相关抗体。
More specifically, the present invention relates to the tumor-associated antibody designated PAM4.
黑色素瘤抗独特型抗体疫苗能模拟肿瘤相关抗原，激发机体的抗肿瘤免疫应答，已在许多动物实验和临床试验中得到证实。
It has been demonstrated that anti-idiotypic antibody vaccines against melanoma can mimic tumor-associated antigens and activate anti-tumor immune responses in many animal models and clinical trials.
应用推荐